Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inhibition of T-cell function by FK 506 and cyclosporine is not accompanied by alterations in intracellular calcium.

× No keyword cloud information.

18 in total

1. Mechanisms of immunosuppression by FK506. Preservation of T cell transmembrane signal transduction.

Authors: B E Bierer; S L Schreiber; S J Burakoff
Journal: Transplantation Date: 1990-06 Impact factor: 4.939

2. Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity.

Authors: N Yoshimura; S Matsui; T Hamashima; T Oka
Journal: Transplantation Date: 1989-02 Impact factor: 4.939

3. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.

Authors: F J Dumont; M J Staruch; S L Koprak; M R Melino; N H Sigal
Journal: J Immunol Date: 1990-01-01 Impact factor: 5.422

4. Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506.

Authors: J E Kay; C R Benzie; M R Goodier; C J Wick; S E Doe
Journal: Immunology Date: 1989-08 Impact factor: 7.397

5. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.

Authors: M J Tocci; D A Matkovich; K A Collier; P Kwok; F Dumont; S Lin; S Degudicibus; J J Siekierka; J Chin; N I Hutchinson
Journal: J Immunol Date: 1989-07-15 Impact factor: 5.422

6. Kidney transplantation under FK 506.

Authors: T E Starzl; J Fung; M Jordan; R Shapiro; A Tzakis; J McCauley; J Johnston; Y Iwaki; A Jain; M Alessiani
Journal: JAMA Date: 1990-07-04 Impact factor: 56.272

7. In vitro locomotion of allosensitized T lymphocyte clones in response to metabolites of arachidonic acid is subset specific.

Authors: M L Jordan; R A Hoffman; E F Debe; R L Simmons
Journal: J Immunol Date: 1986-07-15 Impact factor: 5.422

Inhibition of T-cell function by FK 506 and cyclosporine is not accompanied by alterations in intracellular calcium.

1. Mechanisms of immunosuppression by FK506. Preservation of T cell transmembrane signal transduction.

2. Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity.

3. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.

4. Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506.

5. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.

6. Kidney transplantation under FK 506.

7. In vitro locomotion of allosensitized T lymphocyte clones in response to metabolites of arachidonic acid is subset specific.

8. Antigen-dependent increase in cytosolic free calcium in specific human T-lymphocyte clones.

9. Cyclosporin A inhibits late steps of T lymphocyte activation after transmembrane signaling.

10. Cyclosporine A inhibits Ca2+-dependent stimulation of the Na+/H+ antiport in human T cells.

Review 1. Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.